FELIX BIOTECHNOLOGY
Felix Biotechnology is working to accelerate the deployment of novel biotherapeutics to manage infectious diseases. Felix Biotechnology's bio-therapeutics targets antibiotic-resistant bacteria to manage infectious diseases precisely and effectively, allowing healthcare professionals to manage urgent microbial challenges in human health.
FELIX BIOTECHNOLOGY
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2019-01-16
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.felixbt.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
720.41 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Global Site Tag
Similar Organizations
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Delonix Bioworks
Delonix Bioworks is working on synthetic biology approaches to develop the next generation medical solutions for infectious diseases.
Current Employees Featured
Founder
Investors List
Small Business Innovation Research
Small Business Innovation Research investment in Grant - Felix Biotechnology
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation investment in Grant - Felix Biotechnology
National Science Foundation
National Science Foundation investment in Grant - Felix Biotechnology
Pioneer Fund
Pioneer Fund investment in Seed Round - Felix Biotechnology
Bossanova Investimentos
Bossanova Investimentos investment in Seed Round - Felix Biotechnology
Y Combinator
Y Combinator investment in Seed Round - Felix Biotechnology
Official Site Inspections
http://www.felixbt.com Semrush global rank: 2.17 M Semrush visits lastest month: 9.18 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Felix Biotechnology"
Felix Biotechnology - Crunchbase Company Profile
Contact Email [email protected] Felix Biotechnology is working to accelerate the deployment of novel biotherapeutics to manage infectious diseases. Felix Biotechnology's bio-therapeutics targets antibiotic-resistant bacteria to …See details»
Felix Biotechnology - Overview, News & Similar companies
Jun 28, 2021 Felix Biotechnology contact info: Phone number: (800) 234-5678 Website: www.felixbt.com What does Felix Biotechnology do? a biopharmaceutical company focused …See details»
Felix Biotechnology | VentureRadar
Website: https://www.felixbt.com/ Develops and deploys phages for combating bacterial infections using machine learning and genome engineering techniques, in ...See details»
Felix Biotechnology - Craft
Felix Biotechnology $150 k in total funding,. See insights on Felix Biotechnology including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Felix Biotechnology: We’re creating programmable therapies - Y …
We’re creating programmable therapies. Founded in 2019 by , Felix Biotechnology has 6 employees based in San Francisco, CA, USA.See details»
Felix Biotechnology | LinkedIn
Felix Biotechnology | 2,794 followers on LinkedIn. Targeted Biotherapeutics | In collaboration with researchers at Yale University and UC Berkeley, Felix Biotechnology is focused on …See details»
Felix’s Competitors, Revenue, Number of Employees, Funding
Felix’s Profile, Revenue and Employees. Felix Biotechnology is a California-based biotechnology company that researches and develops novel biotherapeutics for drug-resistant bacterial …See details»
Felix Biotechnology - VentureRadar
SABIEDRIBA AR IEROBEZOTU ATBILDIBU LATIMA Latvia n/a Rigvir Group is a private organization constituted of several companies which have been developing oncolytic …See details»
Felix Biotechnology Awarded Competitive Grant from the National …
Sep 2, 2021 SOUTH SAN FRANCISCO, Calif., Sept. 2, 2021 /PRNewswire/ -- The National Science Foundation (NSF) awarded Felix Biotechnology a Small Business Innovation …See details»
Cystic Fibrosis Foundation Invests in Felix ... - Markets Insider
Mar 3, 2022 SOUTH SAN FRANCISCO, Calif., March 3, 2022 /PRNewswire/ -- Felix Biotechnology — a biopharmaceutical company focused on developing first-in-class,...See details»
Felix Biotechnology Awarded Competitive Grant from …
Jul 14, 2022 /PRNewswire/ -- Felix Biotechnology has been awarded a Small Business Innovation Research (SBIR) Phase I grant for $314,411 from the National Institute of...See details»
Felix Biotechnology - Point72 Ventures
Felix uses high throughput testing and CRISPR technology to design synthetic phage viruses to combat anti-microbial resistance bacteria.See details»
TFF Pharmaceuticals and Felix Biotechnology Sign Letter of Intent …
Nov 5, 2020 Felix Biotechnology: Robert McBride CEO Felix Biotechnology [email protected] Release Summary TFF Pharmaceuticals and Felix Biotechnology sign Letter of Intent for a …See details»
Cystic Fibrosis Foundation Invests in Felix Biotechnology as They ...
Mar 3, 2022 Cystic Fibrosis Foundation Invests in Felix Biotechnology as They Advance New Therapies Targeting Chronic Infections in Cystic Fibrosis This new funding from the CF …See details»
Antibiotic Resistance Emergency – Paul Turner & Robert McBride
Paul Turner & Robert McBride, co-founders of Felix Biotechnology (felixbt.com), discuss the growing problem of antibiotic resistance and the new therapies on the horizon. In this podcast …See details»
Felixbt - Facebook
Felixbt. In collaboration with researchers at Yale University, UC Berkeley and Stanford, Felix Biotechnology is working to expedite the commercial deployment of phage therapies to …See details»
Concerns About Antibiotic Failures – Paul Turner & Robert …
Jan 27, 2020 In this informative podcast, Paul Turner & Robert McBride, the co-founders of Felix Biotechnology (felixbt.com), provide an overview of antibiotic resistance and what Felix …See details»
Felix Biotechnology announces initiation of the CYPHY Phase 1/2 …
SAN FRANCISCO, Jan. 7, 2021 /PRNewswire/ -- Felix Biotechnology today announced the initiation of CYPHY, a Phase 1/2 investigator-initiated single center trial at Yale University for …See details»
The Felix Organization
The Felix Organization provides inspiring opportunities and new experiences to enrich the lives of children who are growing up in the foster care system. "Thank you for a wonderful experience …See details»
Felix Biotechnology to Collaborate with AnimalBiome on a Novel …
Jan 14, 2022 /PRNewswire/ -- Felix Biotechnology — a biotechnology company focused on developing first-in-class, accessible, antibacterial therapies to treat drug-resistant...See details»